Senior Director of Engineering — Precision Medicine & Computational Biology
Cellworks Group Inc. · San Francisco, CA
Heads the engineering division at Cellworks Group — the backbone of Cellworks Biosimulation technology and its proprietary Computational Omics Biology Model (CBM): a mechanistic network of 6,000+ human genes, 30,000+ molecular species, and 600,000+ molecular interactions.
Led engineering of Singula™, Singula Lung™, and Ventura™ platforms powering personalized therapy biosimulation — predicting patient-specific Therapy Response Index (TRI) scores across multiple oncology indications. Singula Lung™ has undergone multiple prospective-retrospective validations across 1,700+ NSCLC patients.
Built 100+ member cross-functional teams spanning computational biology, AI/ML, and cloud infrastructure. Background in engineering coupled with deep understanding of cancer biology drives the platform's continued advancement.
Prospective-retrospective validations: myCare-022-05 (446 pts, ASCO 2021), myCare-203A (453 VA pts, WCLC 2022), 2024 WCLC (553+710 Flatiron-FMI cohort). OS/PFS/CR prediction beyond NCCN-guideline and PD-L1 factors.
myCare-020 (AML & MDS Singula™ classifier), myCare-023 (416 AML patients, TRI predicted CR p<0.0001). ETP-ALL computational classification with WES/aCGH genomic input.
myCare-024 (GBM OS/PFS for 18+ NCCN therapies), myCare-004 (esophageal adenocarcinoma, Cambridge University). Studies across PDAC, LGG, and gastric cancer.
Proprietary enterprise AI agentic solution achieving 90%+ accuracy with 25–30% cost reduction versus competitors. In evaluation with major enterprises.
Platform validated across AML, MDS, NSCLC, GBM, ESAD, PDAC, ETP-ALL
Cash awards for outstanding Program Management — three consecutive years
Created computational biology algorithms powering the entire platform
Deposited HPV E16 Onco Protein structure (PDB ID: 1VZN)
1st Rank in Genomics & Proteomics at University level
"Best Teacher 2005–2006" — Bharath University, Chennai